AMERICAN STRATEGIC INVESTM-A (NYC) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:NYC - US6494393043 - Common Stock
7.7 USD
+0.4 (+5.48%)
NYC gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. NYC may be in some trouble as it scores bad on both profitability and health. NYC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
NYC had negative earnings in the past year.
NYC had a negative operating cash flow in the past year.
In the past 5 years NYC always reported negative net income.
In the past 5 years NYC always reported negative operating cash flow.
1.2 Ratios
NYC has a worse Return On Assets (-19.70%) than 76.56% of its industry peers.
With a Return On Equity value of -257.29%, NYC is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.7% | ||
| ROE | -257.29% | ||
| ROIC | N/A |
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NYC has a Gross Margin of 25.39%. This is comparable to the rest of the industry: NYC outperforms 54.69% of its industry peers.
In the last couple of years the Gross Margin of NYC has declined.
NYC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
2. Health
2.1 Basic Checks
NYC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NYC has been increased compared to 1 year ago.
The number of shares outstanding for NYC has been increased compared to 5 years ago.
The debt/assets ratio for NYC is higher compared to a year ago.
2.2 Solvency
NYC has an Altman-Z score of -2.15. This is a bad value and indicates that NYC is not financially healthy and even has some risk of bankruptcy.
NYC has a worse Altman-Z score (-2.15) than 84.38% of its industry peers.
A Debt/Equity ratio of 9.80 is on the high side and indicates that NYC has dependencies on debt financing.
The Debt to Equity ratio of NYC (9.80) is worse than 85.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 9.8 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.15 |
ROIC/WACCN/A
WACC4.54%
2.3 Liquidity
NYC has a Current Ratio of 0.44. This is a bad value and indicates that NYC is not financially healthy enough and could expect problems in meeting its short term obligations.
NYC has a Current ratio of 0.44. This is amonst the worse of the industry: NYC underperforms 84.38% of its industry peers.
A Quick Ratio of 0.44 indicates that NYC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.44, NYC is doing worse than 81.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.44 |
3. Growth
3.1 Past
NYC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.24%.
Looking at the last year, NYC shows a decrease in Revenue. The Revenue has decreased by -2.03% in the last year.
NYC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.10% yearly.
EPS 1Y (TTM)-79.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-0.1%
Revenue growth 5Y0.1%
Sales Q2Q%-20.58%
3.2 Future
The Earnings Per Share is expected to decrease by -59.84% on average over the next years. This is quite bad
NYC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.65% yearly.
EPS Next Y-312.03%
EPS Next 2Y-100.83%
EPS Next 3Y-59.84%
EPS Next 5YN/A
Revenue Next Year3.15%
Revenue Next 2Y3.17%
Revenue Next 3Y2.65%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NYC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NYC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYC is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 94.92 |
4.3 Compensation for Growth
NYC's earnings are expected to decrease with -59.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-100.83%
EPS Next 3Y-59.84%
5. Dividend
5.1 Amount
No dividends for NYC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:NYC (12/3/2025, 4:10:03 PM)
7.7
+0.4 (+5.48%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners3.33%
Inst Owner Change-31.62%
Ins Owners5.5%
Ins Owner Change10.25%
Market Cap20.56M
Revenue(TTM)62.71M
Net Income(TTM)-91.38M
Analysts45
Price TargetN/A
Short Float %0.06%
Short Ratio0.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.37 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.58 | ||
| P/tB | 0.58 | ||
| EV/EBITDA | 94.92 |
EPS(TTM)-25.61
EYN/A
EPS(NY)-12.18
Fwd EYN/A
FCF(TTM)-4.33
FCFYN/A
OCF(TTM)-3.85
OCFYN/A
SpS20.55
BVpS13.3
TBVpS13.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.7% | ||
| ROE | -257.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 25.39% | ||
| FCFM | N/A |
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
F-Score3
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 9.8 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 91.21 | ||
| Cap/Depr | 8.47% | ||
| Cap/Sales | 2.33% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.44 | ||
| Altman-Z | -2.15 |
F-Score3
WACC4.54%
ROIC/WACCN/A
Cap/Depr(3y)13.9%
Cap/Depr(5y)12.89%
Cap/Sales(3y)5.75%
Cap/Sales(5y)5.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.28%
EPS Next Y-312.03%
EPS Next 2Y-100.83%
EPS Next 3Y-59.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-0.1%
Revenue growth 5Y0.1%
Sales Q2Q%-20.58%
Revenue Next Year3.15%
Revenue Next 2Y3.17%
Revenue Next 3Y2.65%
Revenue Next 5YN/A
EBIT growth 1Y7.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.33%
OCF growth 3YN/A
OCF growth 5YN/A
AMERICAN STRATEGIC INVESTM-A / NYC FAQ
What is the ChartMill fundamental rating of AMERICAN STRATEGIC INVESTM-A (NYC) stock?
ChartMill assigns a fundamental rating of 0 / 10 to NYC.
Can you provide the valuation status for AMERICAN STRATEGIC INVESTM-A?
ChartMill assigns a valuation rating of 0 / 10 to AMERICAN STRATEGIC INVESTM-A (NYC). This can be considered as Overvalued.
Can you provide the profitability details for AMERICAN STRATEGIC INVESTM-A?
AMERICAN STRATEGIC INVESTM-A (NYC) has a profitability rating of 0 / 10.
What is the expected EPS growth for AMERICAN STRATEGIC INVESTM-A (NYC) stock?
The Earnings per Share (EPS) of AMERICAN STRATEGIC INVESTM-A (NYC) is expected to decline by -312.03% in the next year.
How sustainable is the dividend of AMERICAN STRATEGIC INVESTM-A (NYC) stock?
The dividend rating of AMERICAN STRATEGIC INVESTM-A (NYC) is 0 / 10 and the dividend payout ratio is 0%.